img

Global Gene Therapy Medicinal Products (GTMP) Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapy Medicinal Products (GTMP) Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Gene Therapy Medicinal Products (GTMP) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gene Therapy Medicinal Products (GTMP) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Monogenic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gene Therapy Medicinal Products (GTMP) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gene Therapy Medicinal Products (GTMP) key companies include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc. Bluebird Bio, Sangamo, Spark Therapeutics are top 3 players and held % share in total in 2022.
Gene Therapy Medicinal Products (GTMP) can be divided into Oral and Injection, etc. Oral is the mainstream product in the market, accounting for % share globally in 2022.
Gene Therapy Medicinal Products (GTMP) is widely used in various fields, such as Cancer, Monogenic, Infectious Disease and Cardiovascular Disease, etc. Cancer provides greatest supports to the Gene Therapy Medicinal Products (GTMP) industry development. In 2022, global % share of Gene Therapy Medicinal Products (GTMP) went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gene Therapy Medicinal Products (GTMP) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Segment by Type
Oral
Injection

Segment by Application


Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gene Therapy Medicinal Products (GTMP) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gene Therapy Medicinal Products (GTMP) introduction, etc. Gene Therapy Medicinal Products (GTMP) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Gene Therapy Medicinal Products (GTMP) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Gene Therapy Medicinal Products (GTMP)
1.1 Gene Therapy Medicinal Products (GTMP) Market Overview
1.1.1 Gene Therapy Medicinal Products (GTMP) Product Scope
1.1.2 Gene Therapy Medicinal Products (GTMP) Market Status and Outlook
1.2 Global Gene Therapy Medicinal Products (GTMP) Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2034)
1.4 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Region (2024-2024)
1.5 Global Gene Therapy Medicinal Products (GTMP) Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034)
1.6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034)
1.6.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034)
1.6.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034)
1.6.4 Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034)
1.6.5 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034)
2 Gene Therapy Medicinal Products (GTMP) Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injection
2.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2024-2024)
2.2.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2024-2034)
3 Gene Therapy Medicinal Products (GTMP) Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Monogenic
3.1.3 Infectious Disease
3.1.4 Cardiovascular Disease
3.1.5 Other
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2024-2024)
3.2.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2024-2034)
4 Gene Therapy Medicinal Products (GTMP) Competition Analysis by Players
4.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2022)
4.3 Date of Key Players Enter into Gene Therapy Medicinal Products (GTMP) Market
4.4 Global Top Players Gene Therapy Medicinal Products (GTMP) Headquarters and Area Served
4.5 Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Therapy Medicinal Products (GTMP) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bluebird Bio
5.1.1 Bluebird Bio Profile
5.1.2 Bluebird Bio Main Business
5.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.1.4 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.1.5 Bluebird Bio Recent Developments
5.2 Sangamo
5.2.1 Sangamo Profile
5.2.2 Sangamo Main Business
5.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.2.4 Sangamo Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.2.5 Sangamo Recent Developments
5.3 Spark Therapeutics
5.3.1 Spark Therapeutics Profile
5.3.2 Spark Therapeutics Main Business
5.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.3.4 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.3.5 Dimension Therapeutics Recent Developments
5.4 Dimension Therapeutics
5.4.1 Dimension Therapeutics Profile
5.4.2 Dimension Therapeutics Main Business
5.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.4.4 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.4.5 Dimension Therapeutics Recent Developments
5.5 Avalanche Bio
5.5.1 Avalanche Bio Profile
5.5.2 Avalanche Bio Main Business
5.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.5.4 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.5.5 Avalanche Bio Recent Developments
5.6 Celladon
5.6.1 Celladon Profile
5.6.2 Celladon Main Business
5.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.6.4 Celladon Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.6.5 Celladon Recent Developments
5.7 Vical Inc.
5.7.1 Vical Inc. Profile
5.7.2 Vical Inc. Main Business
5.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.7.4 Vical Inc. Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.7.5 Vical Inc. Recent Developments
5.8 Advantagene
5.8.1 Advantagene Profile
5.8.2 Advantagene Main Business
5.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.8.4 Advantagene Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2024-2024)
5.8.5 Advantagene Recent Developments
6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Therapy Medicinal Products (GTMP) Market Dynamics
11.1 Gene Therapy Medicinal Products (GTMP) Industry Trends
11.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
11.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
11.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Gene Therapy Medicinal Products (GTMP) Market Size Share by Region (2024-2024)
Table 4. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2024)
Table 9. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Table 11. North America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2024)
Table 24. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2034)
Table 26. North America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2022)
Table 39. Date of Key Players Enter into Gene Therapy Medicinal Products (GTMP) Market
Table 40. Global Gene Therapy Medicinal Products (GTMP) Key Players Headquarters and Area Served
Table 41. Gene Therapy Medicinal Products (GTMP) Product Solution and Service
Table 42. Global Gene Therapy Medicinal Products (GTMP) Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bluebird Bio Basic Information List
Table 45. Bluebird Bio Description and Business Overview
Table 46. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 47. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Bluebird Bio (2024-2024)
Table 48. Bluebird Bio Recent Developments
Table 49. Sangamo Basic Information List
Table 50. Sangamo Description and Business Overview
Table 51. Sangamo Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 52. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Sangamo (2024-2024)
Table 53. Sangamo Recent Developments
Table 54. Spark Therapeutics Basic Information List
Table 55. Spark Therapeutics Description and Business Overview
Table 56. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 57. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Spark Therapeutics (2024-2024)
Table 58. Spark Therapeutics Recent Developments
Table 59. Dimension Therapeutics Basic Information List
Table 60. Dimension Therapeutics Description and Business Overview
Table 61. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 62. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Dimension Therapeutics (2024-2024)
Table 63. Dimension Therapeutics Recent Developments
Table 64. Avalanche Bio Basic Information List
Table 65. Avalanche Bio Description and Business Overview
Table 66. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 67. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Avalanche Bio (2024-2024)
Table 68. Avalanche Bio Recent Developments
Table 69. Celladon Basic Information List
Table 70. Celladon Description and Business Overview
Table 71. Celladon Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 72. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Celladon (2024-2024)
Table 73. Celladon Recent Developments
Table 74. Vical Inc. Basic Information List
Table 75. Vical Inc. Description and Business Overview
Table 76. Vical Inc. Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 77. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Vical Inc. (2024-2024)
Table 78. Vical Inc. Recent Developments
Table 79. Advantagene Basic Information List
Table 80. Advantagene Description and Business Overview
Table 81. Advantagene Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
Table 82. Revenue (US$ Million) in Gene Therapy Medicinal Products (GTMP) Business of Advantagene (2024-2024)
Table 83. Advantagene Recent Developments
Table 84. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2024) & (US$ Million)
Table 85. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 86. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2024) & (US$ Million)
Table 87. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 88. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 89. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Region (2024-2024)
Table 92. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Region (2024-2034)
Table 93. Latin America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 94. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2024) & (US$ Million)
Table 95. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 96. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 97. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2024) & (US$ Million)
Table 98. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 99. Gene Therapy Medicinal Products (GTMP) Market Trends
Table 100. Gene Therapy Medicinal Products (GTMP) Market Drivers
Table 101. Gene Therapy Medicinal Products (GTMP) Market Challenges
Table 102. Gene Therapy Medicinal Products (GTMP) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Gene Therapy Medicinal Products (GTMP) Market Share by Regions: 2022 VS 2034
Figure 4. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Oral
Figure 11. Global Oral Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Injection
Figure 13. Global Injection Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Gene Therapy Medicinal Products (GTMP) Market Size Share by Type: 2022 & 2034
Figure 15. North America Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Figure 16. Europe Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Figure 20. Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Monogenic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Infectious Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Cardiovascular Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Gene Therapy Medicinal Products (GTMP) Market Size Share by Application: 2022 & 2034
Figure 26. North America Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2034)
Figure 27. Europe Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2024-2034)
Figure 31. Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Gene Therapy Medicinal Products (GTMP) Market Share in 2022
Figure 33. North America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2024-2034)
Figure 34. United States Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 37. France Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Region (2024-2034)
Figure 43. China Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 47. India Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2024-2034)
Figure 50. Mexico Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Share by Country (2024-2034)
Figure 53. Turkey Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Gene Therapy Medicinal Products (GTMP) Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report